Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userRole of Surgery in theManagement of Cancer of Body and Tail of Pancreas
دور المعالجة الجراحية في تدبير سرطان جسم و ذيل البنكرياس
526
0 11
0
(
0
)
Added by
Damascus University ورقة بحثية
Publication date
2009
fields
Medicine
and research's language is
العربية
Authors
حمود نصر( باحث )
Created by
Shamra Editor
Ask ChatGPT about the research
تسليط الضوء على التدبير المتبع في سرطان جسم و ذيل البنكرياس مع تحديد دور المعالجة الجراحية في تدبير هذه الأورام. أجريت الدراسة بالطريق الراجع إِذ شملت جميع المرضى المقبولين في مستشفى الأسد الجامعي بتشخيص سرطان في جسم أو ذيل البنكرياس بين عامي 2003 و 2008 و جمعت المعلومات من خلال مراجعة ملفات المرضى، و التقارير الشعاعية، و تقارير الجراحة.
Evaluation of the management of cancer in the body and tail of the pancreas with determining the role of surgery in the management of these tumors. The study was performed retrospectively. It included all patients who were admitted in Al Assad University Hospital in Damascus between 2003 and 2008 in the diagnosis of cancer in the body or tail of the pancreas. The data were collected by reviewing the hospital files, radiological reports, and surgical reports of these patients.
Artificial intelligence review:
Research summary
تناقش هذه الدراسة دور المعالجة الجراحية في تدبير سرطان جسم وذيل البنكرياس، حيث تم إجراء دراسة رجعية شملت 66 مريضًا تم قبولهم في مستشفى الأسد الجامعي بدمشق بين عامي 2003 و2008. أظهرت النتائج أن 53% من الحالات كانت غير قابلة للاستئصال الجراحي، بينما خضع 47% من المرضى للجراحة، وتم إجراء الاستئصال الجذري للورم في 35% من هؤلاء المرضى، أي بنسبة 17% من إجمالي المرضى. بلغت نسبة الوفيات بعد الجراحة 8%، ونسبة المضاعفات الكبرى 20%. تشير الدراسة إلى أهمية التصنيف المرحلي الدقيق قبل الجراحة لتحديد إمكانية الاستئصال الجراحي، كما تؤكد على دور المعالجة التلطيفية في الحالات غير القابلة للاستئصال.
Critical review
دراسة نقدية: تعتبر هذه الدراسة مهمة لأنها تسلط الضوء على تحديات علاج سرطان جسم وذيل البنكرياس، ومع ذلك، هناك بعض النقاط التي يمكن تحسينها. أولاً، كان من الممكن أن تشمل الدراسة عددًا أكبر من المرضى لزيادة قوة النتائج. ثانيًا، لم تتناول الدراسة بشكل كافٍ تأثير العلاجات المساعدة مثل العلاج الكيميائي والإشعاعي على نتائج المرضى. وأخيرًا، كان من المفيد تقديم تحليل أكثر تفصيلًا للعوامل التي تؤثر على نجاح الجراحة والمضاعفات.
Questions related to the research
-
ما هي نسبة الحالات التي كانت غير قابلة للاستئصال الجراحي في الدراسة؟
كانت نسبة الحالات غير القابلة للاستئصال الجراحي 53%.
-
ما هي نسبة الوفيات بعد الجراحة وفقًا للدراسة؟
بلغت نسبة الوفيات بعد الجراحة 8%.
-
ما هي أهمية التصنيف المرحلي قبل الجراحة وفقًا للدراسة؟
التصنيف المرحلي قبل الجراحة مهم لتحديد إمكانية الاستئصال الجراحي.
-
ما هي نسبة المرضى الذين خضعوا للاستئصال الجذري للورم؟
تم إجراء الاستئصال الجذري للورم في 35% من المرضى الذين خضعوا للجراحة، أي بنسبة 17% من إجمالي المرضى.
References used
Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996; 223:506-12
Falconi M, Mantovani W, Bettini R, Talamini G, Bassi C, Cascinu S, et al. Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? Dig Liver Dis 2003; 35:421-7
Dalton, RR; Sarr, MG; van Heerden, JA; Colby, TV. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992May;111(5):489–494
rate research
Read More
A retrospective study included 25 cases with inflammatory breast cancer. The patients were admitted to AL-Assad University Hospital, Lattakia, Syria (average age 55, and range 49-61 years old). The most common clinical signs and symptoms were: erythe
ma 100%, edema 100%, enlarged axillary nodes 100%, Nipple flattened/inverted 96%, warm Breast 92%, Ridges/thickening of breast 84%, Peau d’orange 88%, painful/tender Breast 88%, and Mass 80%. Mammography findings were: an increase in skin thickness 100%, an increased tissue density in the involved breast 100%, and an asymmetric widening of the sub-cutaneous lymphatic vessels 33.33%. 80% of cases were diagnosed as stage IV. All patients received primary neoadjuvant chemotherapy for three cycles. After that a modified radical breast mastectomy and axillary lymph nodes dissection were performed for all patients. The wound edges were closed primarily after dissecting the skin in 76%, for 4 patients 16% a split-thickness skin grafts were performed, and for 2 patients 8% a Latissimus dorsi pedicled myocutaneous flap was performed.
This study was carried out in AL-ASSAD University Hospital during the years 2005-
2015, and included 56 patients who have been treated of gastric cancer. Male: Female ratio
was 1:1.85, the peak incidence was in the 6th and 7th decades 60%, the heig
hest incidence
was in lower third of stomach in 65% of cases. Adenocarcinoma (FUNGATING FORM)
was the most common pathological macroscopic form 45%,. The most common operation
was subtotal gastrectomy 71.05% with Omega, Brown anastomosis 52.63%, interiorly of
the colon, in the two third of cases.D1 dissection was performed in 92.1% of cases,
compared with D2 dissection which was performed in 6.9% of cases.Spleenectoy was
performed in 15.7% of cases, and the cholecystectomy was performed in 2.5% of
cases.Stage ɪɪ and stage ɪɪɪ constitute 90% of cases.
recurrence is a major problem which affects 40% of Breast cancer patients . Bcl2 is an antiapoptotic protein which is implicated in many cases of cancer development and cancer resistance to therapy.
Aim of study : investigate the role of Bcl2 in recurrence in Breast cancer patients
The standard treatment for superficial TCC of the bladder is the endoscopic
resection of all visible tumours. Transurethral resection (TUR) may fail to control superficial disease,
especially in patients with higher tumour stages (T1), in addition
to the high recurrence rate.
To evaluate the role of a second transurethral resection (early re-resection) in reducing the high
recurrence rate of T1 bladder tumours .
Background: people with cancer experience great changes in their life as a result of disease, treatment and disease prognosis which affect their quality of life .with the goal of investigating breast cancer patient's quality of life during chemother
apy in Tishreen hospital in Latakia..
Methods: 60 patients were invited to complete the European organization of research and treatment quality of life questionnaire version 3 and breast cancer quality of life module during their early stage of chemotherapy.
Results : the results show that the (73.3%) were under the age of fifty and half of them reported total health status score under (50) which reflects low quality of life in addition to impaired psychological ,social, cognitive and role functioning. Also more than 67% of patient suffered from chemotherapy- related side effects as nausea and vomiting, dyspnea, loss of appetite, insomnia, and fatigue. In addition to variance in quality of life scores according to age, marital status, occupation and level of education without changing of it by educational level. In addition to that the majority of patient had impaired sexual function and upset of hair loss and arm symptoms but with positive and optimistic future.
perspective. No significant differences in quality of life scores were found between urban and rural patients. Conclusion. Health care provider should assess routinely cancer patient quality of life during treatment to ascertain of providing appropriate care with supportive services for all patients
suggested questions
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
